Get started
Author

Tina Ken Schramm

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
2010 · Morten L. Hansen, Rikke Sørensen, et al. · Archives of Internal Medicine · 865
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk
2008 · Tina Ken Schramm, Gunnar H. Gislason, et al. · Circulation · 541
Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction
2006 · Gunnar H. Gislason, Søren Jacobsen, et al. · Circulation · 446
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
2011 · Tina Ken Schramm, Gunnar Hilmar Gislason, et al. · European Heart Journal · 421
Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure
2009 · Gunnar H. Gislason, Jeppe N. Rasmussen, et al. · Archives of Internal Medicine · 295
Location of Cardiac Arrest in a City Center
2009 · Fredrik Folke, Freddy Knudsen Lippert, et al. · Circulation · 221
Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes
2007 · Gunnar H. Gislason, Jeppe N. Rasmussen, et al. · Circulation · 186
Differences Between Out-of-Hospital Cardiac Arrest in Residential and Public Locations and Implications for Public-Access Defibrillation
2010 · Fredrik Folke, Gunnar H. Gislason, et al. · Circulation · 179
Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals
2010 · Emil Loldrup Fosbøl, Fredrik Folke, et al. · Circulation Cardiovascular Quality and Outcomes · 167
The pattern of use of non‐steroidal anti‐inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people
2008 · Emil Loldrup Fosbøl, Gunnar H Gislason, et al. · Pharmacoepidemiology and Drug Safety · 146
Prognosis in Heart Failure and the Value of β-Blockers Are Altered by the Use of Antidepressants and Depend on the Type of Antidepressants Used
2009 · Emil Loldrup Fosb�l, Gunnar H. Gislason, et al. · Circulation Heart Failure · 71
Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study
2010 · Casper H Jørgensen, Gunnar H Gislason, et al. · Cardiovascular Diabetology · 61
PDF
Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study
2014 · Ulrik M. Mogensen, Charlotte Andersson, et al. · Diabetologia · 52
PDF
Persistent Socio-economic Differences in Revascularization After Acute Myocardial Infarction Despite a Universal Health Care System—A Danish Study
2007 · Jeppe N. Rasmussen, Søren Rasmussen, et al. · Cardiovascular Drugs and Therapy · 39
Different angiotensin‐converting enzyme inhibitors have similar clinical efficacy after myocardial infarction
2007 · Morten L. Hansen, Gunnar H. Gislason, et al. · British Journal of Clinical Pharmacology · 31
PDF
Increased Mortality Associated With Low Use of Clopidogrel in Patients With Heart Failure and Acute Myocardial Infarction Not Undergoing Percutaneous Coronary Intervention
2010 · Lisbeth Bonde, Rikke Sorensen, et al. · Journal of the American College of Cardiology · 22
PDF
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality—A retrospective nationwide study
2014 · Ulrik Madvig Mogensen, Charlotte Andersson, et al. · Diabetes Research and Clinical Practice · 17
Mortality and Reinfarction among Patients Using Different Beta-Blockers for Secondary Prevention after a Myocardial Infarction
2008 · Søren Skøtt Andersen, Morten Lock Hansen, et al. · Cardiology · 16
Abstracts from the 38th Annual Meeting of the Histiocyte Society Held Virtually and In Person in Stockholm, Sweden from September 18‐20, 2022
2022 · Bjørn, Jon, Brooks, Patrick Terrence, et al. · Pediatric Blood & Cancer · 14
Hospital Variation in Use of Secondary Preventive Medicine After Discharge for First Acute Myocardial Infarction During 1995–2004
2008 · Søren Rasmussen, Steen Z. Abildstrom, et al. · Medical Care · 12
Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study
2010 · Ditte‐Marie Bretler, Peter Riis Hansen, et al. · British Journal of Clinical Pharmacology · 9
National Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark
2010 · Helena Dominguez, Tina Kenn Schramm, et al. · Frontiers in Pharmacology · 4
PDF
Why epidemiological and clinical intervention studies often give different or diverging results?
2008 · Henrik E. Poulsen, Jon Trærup Andersen, et al. · IUBMB Life · 4
PDF
Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006
2011 · Mette L Norgaard, Charlotte Andersson, et al. · Cardiovascular Diabetology · 3
PDF
A Randomized Trial to Investigate the Effects of Low‐Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT)
2026 · Adam Femerling Langhoff, Niklas Dyrby Johansen, et al. · Journal of Clinical Hypertension · 1
Works count: 34
Citation count: 3,826
H-index: 17
I10-index: 20
Year
Topic
Type